Paradigm shifts in the treatment of HR+ HER2 - mBC

Updated: Sep 18, 2020

Dr Chandrakanth M V, Medical Oncologist, Narayana Superspeciality Hospital, Kolkata, talks about the paradigm shifts in the treatment of HR+ HER2 Metastatic Breast Cancer (mBC). He discusses the details of the Palbociclib trials. He also takes us through the data points and statistics available from the clinical trials.

#BreastCancer, #HER2, #Oncology, #Cancer



127 views0 comments

Recent Posts

See All